Skip to main content

Table 2 Association of vital capacity with serum markers by multiple linear regression analysis

From: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease

  βest (95% confidence interval) r P
IL-15 -0.36 (-0.57 to -0.14) -0.40 0.002
Inflammatory activity 1.65 (-6.45 to 9.75) 0.05 0.691
Anticentromer antibodies 19.49 (9.72 to 29.27) 0.46 <0.001
Anti-scleroderma-70 antibodies -0.60 (-10.49 to 9.30) -0.02 0.605
  1. Coefficient of determination = 37%. Inflammatory activity describes an increased erythrocyte sedimentation rate, increased C-reactive protein or increased orosomucoid either alone or in combination.
\